References

1. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837-1847. View
2. Goff DCJ, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, et al. (2014) American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation 129: S49-S73. View
3. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, et al. (1995) Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99 m sestamibi myocardial perfusion SPECT. J Am Coll Cardiol 26: 639-647. View
4. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, et al. (1996) Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 93: 905-914.
5. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, et al. (1993) Separate acquisition rest thalium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 22: 1455-1464. View
6. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, et al. (1998) Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 97: 535-543. View
7. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, et al. (2012) ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012; 60: e44-e164. View
8. Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S (2008) Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging 35: 319-328. View
9. Matsuo S, Nakajima K, Horie M, Nakae I, Nishimura T; J-ACCESS Investigators (2008) Prognostic value of normal stress myocardial perfusion imaging in Japanese population. Circ J 72: 611-617. View
10. Hashimoto A, Nakata T, Wakabayashi T, Kusuoka H, Nishimura T (2009) Incremental prognostic value of stress/rest gated perfusion SPECT in patients with coronary artery disease--subanalysis of the J-ACCESS study. Circ J 73: 2288-2293. View
11. Hatta T, Nishimura S, Nishimura T (2009) Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Med Mol Imaging 36: 1835-1841. View
12. Nakajima K, Yamasaki Y, Kusuoka H, Izumi T, Kashiwagi A, et al. (2009) Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging. Eur J Nucl Med Mol imaging 36: 2049-2057. View
13. Joki N, Hase H, Kawano Y, Nakamura S, Nakajima K, et al. (2014) Myocardial perfusion imaging for predicting cardiac events in Japanese patients with advanced chronic kidney disease: 1-year interim report of the J-ACCESS 3 investigation. Eur J Nucl Med Mol Imaging 41: 1701-1709. View
14. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659-663. View
15. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305.
16. Herzog CA, Asinger RW, Berger AK, Charytan DM, Díez J, et al. (2011) Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 80: 572- 586. View
17. De Vriese AS, Vandecasteele SJ, Van den Bergh B, De Geeter FW (2012) Should we screen for coronary artery disease in asymptomatic chronic dialysis patients? Kidney Int 81: 143-151.
18. Sosnov J, Lessard D, Goldberg RJ, Yarzebski J, Gore JM (2006) Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective. Am J Kidney Dis 47: 378-384. View
19. Herzog CA, Littrell K, Arko C, Frederick PD, Blaney M (2007) Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 116: 1465-1472. View
20. Lameire N Adam A, Becker CR, Davidson C, McCullough PA, et al. (2006) Baseline renal function screening. Am J Cardiol 98: 21K-26K. View
21. Davidson CJ, Hlatky M, Morris KG, Pieper K, Skelton TN, et al. (1989) Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 110: 119- 124. View
22. Moroi M, Tamaki N, Nishimura M, Haze K, Nishimura T, et al. (2013) Association between abnormal myocardial fatty acid metabolism and cardiac-derived death among patients undergoing hemodialysis: Results from a cohort study in Japan. Am J Kidney Dis 61: 466-475. View
23. Yoda S, Nakanishi K, Tano A, Kasamaki Y, Kunimoto S, et al. (2012) Risk stratification of cardiovascular events in patients at all stages of chronic kidney disease using myocardial perfusion SPECT. J Cardiol 60: 377-382. View
24. Yoda S, Nakanishi K, Tano A, Hori Y, Suzuki Y, et al. (2015) Significance of Worsening Renal Function and Nuclear Cardiology for Predicting Cardiac Death in Patients with Known or Suspected Coronary Artery Disease. J Cardiol 66: 423-429. View
25. Slomka PJ, Nishina H, Berman DS, Akincioglu C, Abidov A, et al. (2005) Automated quantification of myocardial perfusion SPECT using simplified normal limits. J Nucl Cardiol 12: 66-77. View
26. Berman DS, Kang X, Gransar H, Gerlach J, Friedman JD, et al. (2009) Quantitative assessment of myocardial perfusion abnormality on SPECT myocardial perfusion imaging is more reproducible than expert visual analysis. J Nucl Cardiol 16: 45-53. View
27. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, et al. (2008) Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117: 1283-1291. View
28. Holly TA, Abbott BG, Al-Mallah M, Calnon DA, Cohen MC, et al. (2010) Single photon-emission computed tomography. J Nucl Cardiol 17: 941-973. View
29. Nakajima K (2010) Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function. Ann Nucl Med 24: 125-135. View
30. Yoda S, Nakanishi K, Tano A, Kasamaki Y, Kunimoto S, et al. (2013) Diagnostic value of automated quantification of nuclear cardiology in Japanese patients with single vessel coronary artery disease: Comparison between Japanese and American normal databases. J Cardiol 62: 224- 229. View
31. Yoda S, Nakanishi K, Tano A, Hori Y, Suzuki Y, et al. (2013) Validation of automated quantification of nuclear cardiology in Japanese patients using total perfusion deficits: comparison with visual assessment. J Cardiol 63: 350-357. View
32. Yoda S, Nakanishi K, Tano A, Hori Y, Suzuki Y, et al. (2014) Usefulness of automated assessment of nuclear cardiology for prediction of major cardiac events in Japanese patients with known or suspected coronary artery disease: comparison with conventional visual assessment in a large-scale prognostic study. J Cardiol 64: 395-400. View
33. Kiriyama T, Kumita S, Moroi M, Nishimura T, Tamaki N, et al. (2015) Interpretative variability and its impact on the prognostic value of myocardial fatty acid imaging in asymptomatic hemodialysis patients in a multicenter trial in Japan. Circ J 79: 153-160. View
34. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS (2003) Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107: 2900-2906. View
35. Moroi M, Yamashina A, Tsukamoto K, Nishimura T; J-ACCESS Investigators (2012) Coronary revascularization does not decrease cardiac events in patients with stable ischemic heart disease but might do in those who showed moderate to severe ischemia. Int J Cardiol 158: 246-252. View
36. Nanasato M, Nakajima K, Fujita H, Zen K, Kohsaka S, et al (2014) Rationale and design of J-ACCESS 4: prognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease. J Cardiol 63: 159-164. View
37. Hori Y, Yoda S, Nakanishi K, Tano A, Suzuki Y, et al. (2015) Myocardial ischemic reduction evidenced by gated myocardial perfusion imaging after treatment results in good prognosis in patients with coronary artery disease. J Cardiol 65: 278-284. View
38. Nakajima K, Matsuo S, Okuyama C, Hatta T, Tsukamoto K, et al. (2012) Cardiac Event Risk in Japanese Subjects Estimated Using Gated Myocardial Perfusion Imaging, in Conjunction With Diabetes Mellitus and Chronic Kidney Disease. Circ J 76: 168-175. View
39. Yoda S, Nakanishi K, Tano A, Hori Y, Suzuki Y, et al. (2016) Major cardiac event risk scores estimated with gated myocardial perfusion imaging in Japanese patients with coronary artery disease. J Cardiol 67: 64-70. View